Rapid and Sustained Improvements in Itch and Quality of Life with Upadacitinib Plus Topical Corticosteroids in Adults and Adolescents with Atopic Dermatitis: 52-Week Outcomes from the Phase 3 AD Up Study
Journal of Dermatological Treatment（2024）
Key words
Atopic dermatitis,disease burden,patient-reported outcome measures,quality of life,upadacitinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined